Cumberland Pharmaceuticals (CPIX) Return on Capital Employed: 2009-2025
Historic Return on Capital Employed for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Sep 2025 value amounting to -0.08%.
- Cumberland Pharmaceuticals' Return on Capital Employed rose 15.00% to -0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.08%, marking a year-over-year increase of 15.00%. This contributed to the annual value of -0.14% for FY2024, which is 2.00% up from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Return on Capital Employed stood at -0.08% for Q3 2025, which was down 15.09% from -0.07% recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Return on Capital Employed registered a high of -0.07% during Q2 2021, and its lowest value of -0.23% during Q3 2024.
- For the 3-year period, Cumberland Pharmaceuticals' Return on Capital Employed averaged around -0.13%, with its median value being -0.09% (2023).
- In the last 5 years, Cumberland Pharmaceuticals' Return on Capital Employed dropped by 14bps in 2024 and then climbed by 15bps in 2025.
- Cumberland Pharmaceuticals' Return on Capital Employed (Quarterly) stood at -0.12% in 2021, then grew by 2bps to -0.09% in 2022, then declined by 8bps to -0.17% in 2023, then increased by 2bps to -0.14% in 2024, then grew by 15bps to -0.08% in 2025.
- Its Return on Capital Employed stands at -0.08% for Q3 2025, versus -0.07% for Q2 2025 and -0.07% for Q1 2025.